**
A recent study has brought to light significant findings regarding the effects of cannabis policy changes worldwide. Researchers have discovered that the commercialisation of cannabis, rather than merely decriminalising it, is the primary factor driving up usage rates and associated mental health problems. This research, published in *Lancet Psychiatry*, raises important questions for policymakers contemplating the future of cannabis legislation.
The Rise of Cannabis Users
Between 2000 and 2025, an international team of researchers conducted a comprehensive analysis of cannabis policy shifts across various countries. Their findings indicate that where cannabis has been sold commercially, such as in the United States and Canada, there has been a notable increase in both consumption and the potency of the drug. Alarmingly, this trend has also been accompanied by a rise in hospital admissions for psychosis and other mental health conditions linked to cannabis use.
In contrast, regions that have opted for decriminalisation—such as parts of Europe, Africa, Oceania, and Asia—have not experienced similar increases in usage or psychiatric disorders. Even in Uruguay, which first legalised cannabis in 2013 under strict government control, there has been no significant spike in consumption. Such findings suggest that the method of cannabis distribution plays a critical role in its overall impact on society.
Insights from the Research
Tom Freeman, a professor of psychology at the University of Bath and lead author of the study, explained, “This rapid shift toward more liberal cannabis policies offers us a unique opportunity to examine the outcomes of these changes.” He pointed out that while decriminalisation and stringent regulation appear to have little effect on usage rates, the commercialisation of cannabis brings a different set of challenges.
Freeman’s analysis highlights that with a for-profit industry, there exists a strong incentive to promote cheaper and more potent products. “This is similar to what we have seen with alcohol and tobacco,” he noted. “When companies aim to maximise profits, the potential for increased harm to users becomes a critical concern.”
The UK’s Cannabis Landscape
In the UK, cannabis is classified as a Class B drug, with possession carrying severe penalties, including up to five years in prison. Recent discussions, spurred by a report from the London Drugs Commission, have questioned the fairness of these sanctions, particularly in light of racial disparities in enforcement. The report revealed that Black individuals are five times more likely to be stopped and searched for drug-related offences compared to their white counterparts.
Despite the long and arduous journey to legalise medical cannabis in the UK, access remains limited, leading many to wonder why recreational use is still heavily penalised.
Global Perspectives on Cannabis Policy
The experiences of other nations provide valuable lessons for the UK and beyond. Sir Robin Murray, a professor of psychiatric research at King’s College London, emphasised the need for caution regarding the commercialisation of cannabis. He stated, “There’s a growing consensus that the commercialisation of supply is the critical factor in determining the social impact of cannabis legalisation.” He expressed concern over the rampant commercialisation observed in North America, where advertising has led to increased consumption akin to that seen with tobacco during its peak.
Conversely, Alex Stevens, a criminology professor at the University of Sheffield, argued that the findings of the review are crucial for policymakers. He asserted, “Research consistently shows that regulated models and decriminalisation do not necessarily lead to increased usage. The fears surrounding these reforms are unfounded based on current evidence.”
Why it Matters
The implications of this study are profound. As countries reconsider their approaches to cannabis legislation, understanding the dynamics of commercialisation versus decriminalisation will be critical. This research underscores the necessity for responsible policymaking that prioritises public health and safety. The findings serve as a clarion call for governments to tread carefully on the path of cannabis legalisation, ensuring that the lessons learned from other nations are taken into account to avoid exacerbating social and mental health crises.
